Drugmakers still struggling to keep up with spiking estrogen patch demand
The pharmaceutical industry is warning that estrogen patches continue to be in shortage in the U.S. as manufacturers struggle to keep up with increased demand linked to federal policy changes issued earlier this year, even as regulators have yet to recognize a lack in supply.
Reported by 1 outlet — The Hill. See all sources ↓
The pharmaceutical industry is warning that estrogen patches continue to be in shortage in the U.S. as manufacturers struggle to keep up with increased demand linked to federal policy changes issued earlier this year, even as regulators have yet to recognize a lack in supply. Manufacturers first reported issues with supplying demand earlier this year...
Read the full report at The Hill ↗
Why it matters
A world story we're tracking; its significance and source trust firm up as more outlets confirm it.
- What's the story?
- The pharmaceutical industry is warning that estrogen patches continue to be in shortage in the U.S. as manufacturers struggle to keep up with increased demand linked to federal policy changes issued earlier this year, even as regulators have yet to recognize a lack in supply.
- How widely is it covered?
- 1 outlet, average source rating 7.0/10.
- When was it last updated?
- 6m ago.
How outlets are framing the same story
Here's how each outlet is covering the story — compare their headlines and timing at a glance.
- Coverage card1 outlet1CoverageScouting report
Drugmakers still struggling to keep up with spiking estrogen patch demand
Sources1TypeCoverageThe Hill